SCHEMBL538951

SCHEMBL538951

C=CCn1[c]cc[c]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL849669 0.64
SCHEMBL1140198 0.62
SCHEMBL87312 0.59 CYP3A4 (0.32)
SCHEMBL17722392 0.59
SCHEMBL14663846 0.59 ALDH1A1 (0.33)
SCHEMBL14877508 0.58 ALDH1A1 (0.37)
Hydrochloric Acid SCHEMBL572769 0.57 CYP3A4 (0.31)
Iodide SCHEMBL2341578 0.57 CYP3A4 (0.31)
Bromide SCHEMBL1045354 0.57 CYP3A4 (0.31)
SCHEMBL15662580 0.56 CYP3A4 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170362213-A1 NITROCATECHOL DERIVATIVES AS COMT INHIBITORS PORTELA & COMPANHIA, S.A. (PT) 2017-12-21 US claimed
US-20150359783-A1 PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF BIAL - PORTELA & CA, S.A. (PT) 2015-12-17 US claimed
US-20150072977-A1 NITROCATECHOL DERIVATIVES AS COMT INHIBITORS BIAL - PORTELA & CA, S.A. (PT) 2015-03-12 US claimed
EP-2413912-A1 PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF Bial-Portela & CA, S.A. (PT) 2012-02-08 EP claimed
EP-2301934-A1 Nitrocatechol derivatives as COMT inhibitors BIAL - Portela & Ca., S.A. (PT) 2011-03-30 EP claimed
US-20100256193-A1 PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF BIAL - PORTELA & CA, S.A. (PT) 2010-10-07 US claimed
WO-2010114404-A1 PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF BIAL - PORTELA & CA., S.A. (PT) 2010-10-07 WO claimed
US-20100168113-A1 Pharmaceutical Compounds BIAL-PORTELA & CA., S.A. (PT) 2010-07-01 US claimed
US-20090054437-A1 Nitrocatechol Derivatives as Comt Inhibitors PORTELA & CA., S.A. (PT) 2009-02-26 US claimed
EP-2027091-A1 NEW PHARMACEUTICAL COMPOUNDS BIAL - Portela & Ca., S.A. (PT) 2009-02-25 EP claimed
EP-1907382-A1 NITROCATECHOL DERIVATIVES AS COMT INHIBITORS Portela & C.A. S.A (PT) 2008-04-09 EP claimed
WO-2007117165-A1 NEW PHARMACEUTICAL COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2007-10-18 WO claimed
WO-2007013830-A1 NITROCATECHOL DERIVATIVES AS COMT INHIBITORS PORTELA & CA. S.A. (PT) 2007-02-01 WO claimed
EP-1439590-A2 Mono-, oligo- and poly-bis(thienyl) arylenes and their use as charge transport materials MERCK PATENT GmbH (DE) 2004-07-21 EP claimed
US-20040119049-A1 Mono-, oligo- and poly-bis(thienyl) arylenes and their use as charge transport materials MERCK PATENT GMBH (DE) 2004-06-24 US claimed
US-20220388999-A1 NITROCATECHOL DERIVATIVES AS COMT INHIBITORS BIAL PORTELA & CA SA (PT) 2022-12-08 US disclosed
EP-2413913-B1 PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THE SAME BIAL PORTELA & CA SA (PT) 2022-05-18 EP disclosed
WO-2007013830-A1 NITROCATECHOL DERIVATIVES AS COMT INHIBITORS PORTELA & CA. S.A. (PT) 2007-02-01 WO disclosed
EP-1439590-A2 Mono-, oligo- and poly-bis(thienyl) arylenes and their use as charge transport materials MERCK PATENT GmbH (DE) 2004-07-21 EP disclosed
US-20040119049-A1 Mono-, oligo- and poly-bis(thienyl) arylenes and their use as charge transport materials MERCK PATENT GMBH (DE) 2004-06-24 US disclosed